Document Detail

Intracoronary beta-blocker before percutaneous intervention protects myocardium.
MedLine Citation:
PMID:  12814988     Owner:  NLM     Status:  MEDLINE    
Ruth SoRelle
Related Documents :
3099628 - Sensitivity to anthracyclines in p388/dx leukaemia cells.
3716828 - Calcium channel blockers and motility disorders of the esophagus.
8784458 - Synthesis and pharmacological testing of dequalinium analogues as blockers of the apami...
9717878 - No association between calcium channel blocker use and confirmed bleeding peptic ulcer ...
7833858 - The unique and shared properties of neuronal growth cones that enable navigation and sp...
9539128 - Periodicity of thalamic synchronized oscillations: the role of ca2+-mediated upregulati...
Publication Detail:
Type:  Comment; News    
Journal Detail:
Title:  Circulation     Volume:  107     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-06-19     Completed Date:  2003-07-01     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e9050-1     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / administration & dosage*
Angioplasty, Transluminal, Percutaneous Coronary* / adverse effects
Heart / drug effects*
Injections, Intra-Arterial
Myocardial Infarction / prevention & control*
Reg. No./Substance:
0/Adrenergic beta-Antagonists
Comment On:
Circulation. 2003 Jun 17;107(23):2914-9   [PMID:  12771007 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Natural history of venous thromboembolism.
Next Document:  A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavir...